Document is current
Any future updates will be listed below
-
Authors
Nilsen, Marci Lee
Belsky, Michael A.
Scheff, Nicole
Johnson, Jonas T.
Zandberg, Dan P.
Skinner, Heath
Ferris, Robert
- License Information
-
More Information
Article History
Accepted: 29 June 2020
First Online: 3 October 2020
Compliance with Ethical Standards
:
: Marci Lee Nilsen declares that she has no conflict of interest. Michael A. Belsky declares that he has no conflict of interest. Nicole Scheff declares that she has no conflict of interest. Jonas T. Johnson declares that he has no conflict of interest. Dan P. Zandberg has received research funding (paid to his institution) from Bristol-Myers Squibb, Merck, Aduro Biotech, Astellas, Lilly, and GlaxoSmithKline. Heath Skinner declares that he has no conflict of interest. Robert Ferris has received research funding/funding for clinical trials from AstraZeneca/MedImmune, Merck, and TTMS; has received compensation for service as a consultant from Aduro Biotech, Iovance Biotherapeutics, Nanobiotix, Ono Pharmaceutical, TTMS, and Torque Therapeutics, Inc.; has served on advisory boards for AstraZeneca/Medimmune, EMD Serono, GlaxoSmithKline, MacroGenics, Merck, Numab Therapeutics AG, Oncorus, Pfizer, PPD, and Regeneron Pharmaceuticals; and owns stock in TTMS.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
